Placebo-controlled superiority trials in type 2 diabetes (T2D) LEADER, SUSTAIN-6, REWIND, and SOUL and in obesity without diabetes (SELECT) demonstrated statistically significant reductions in major adverse cardiovascular events (MACE) of approximately 12%26% [3], [4], [10][12]
3 (download XLSX Statistical source data
Toms JA, ONeill E, Wiegmann AL, Adepoju J, Raj MS
Medicare Advantage plans must give you the same coverage as Original Medicare and should, therefore, cover B12 injections when medically necessary
Even when clinical criteria are met, many regional BCBS plans classify Wegovy as a lifestyle medication rather than a medical necessity, placing it in higher cost-sharing tiers with substantial copayments or coinsurance obligations